Adenosine
USP/1012123 - United States Pharmacopeia (USP) Reference Standard
Synonym: 9-β-D-Ribofuranosyladenine; Adenine riboside; Adenine-9-β-D-ribofuranoside
CAS Number: 58-61-7
Empirical Formula (Hill Notation): C10H13N5O4
Molecular Weight: 267.24
MDL Number: MFCD00005752
Linear Formula: C10H13N5O4
Product Type: Chemical
| API family | adenosine |
| application(s) | pharmaceutical (small molecule) |
| description | API family: adenosine |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C10H13N5O4/c11-8-5-9(1 |
| InChI key | OIRDTQYFTABQOQ-KQYNXXCUSA |
| manufacturer/tradename | USP |
| mp | 234-236 °C (lit.) |
| SMILES string | Nc1ncnc2n(cnc12)[C@@H]3O[ |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Adenosine USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as: • Adenosine Injection • Heparin Sodium |
| Biochem/physiol Actions: | Endogenous neurotransmitter at adenosine receptors. Cardioprotective effects may relate to activation of A1 adenosine receptors. The antiplatelet and anti−inflammatory actions of adenosine appear to be mediated via the A2 adenosine receptor. In contrast, adenosine appears to be a pro-inflammatory mediator in asthma and chronic obstructive pulmonary disease (COPD). |
| General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Ph |
| Other Notes: | Sales restrictions may apply. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| mp | 234-236 °C (lit.) |
| UNSPSC | 41116107 |